已收盤 08-07 16:00:00 美东时间
+0.490
+8.02%
RBC Capital analyst Leonid Timashev maintains Nuvation Bio (NYSE:NUVB) with a Outperform and raises the price target from $19 to $20.
08-08 03:58
华盛资讯8月6日讯,NUVATION BIO公布2026财年Q2业绩,公司Q2营收0.32亿美元,同比增长555.7%,归母净利润亏损0.63亿美元,同比亏损扩大6.5%。
08-06 19:54
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 5.88 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $31.687 million which...
08-06 18:58
今日重点评级关注:BTIG:上调Outlook Therapeutics"买入"评级,目标价4美元;TD Cowen:维持Nakamoto"买入"评级,目标价从1美元升至17美元
07-28 11:34
今日重点评级关注:伯恩斯坦:维持ServiceNow"跑赢大市"评级,目标价从236美元升至248美元;HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从46美元升至52美元
07-24 11:37
Wedbush analyst David Nierengarten reiterates Nuvation Bio (NYSE:NUVB) with a Outperform and maintains $11 price target.
07-23 22:21
Global oncology firm Nuvation Bio Inc. (NYSE:NUVB) on Monday revealed updated long-term data from a mid-stage trial evaluating safusidenib for grade 2 IDH1-mutant glioma patients who have not yet received chemotherapy or radiotherapy. Following the announcement, the stock jumped over 11%. Grade 2 ID...
07-20 23:44
今日重点评级关注:Canaccord Genuity:维持AtaiBeckley"买入"评级,目标价从15美元升至17美元;Truist Securities:维持NUVATION BIO"买入"评级,目标价从12美元升至13美元
07-08 15:31
Truist Securities analyst Gregory Renza maintains Nuvation Bio (NYSE:NUVB) with a Buy and raises the price target from $12 to $13.
07-07 20:26
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 2% on Thursday. Shares of H.B. Fuller Company (NYSE:FUL) fell sharply in pre-market trading following second-quarter results. H.B. Fuller posted upbeat earnings for the second quarter and raised its FY2026 ear...
06-25 20:08